Cynosure, Inc. (CYNO) Downgraded by Aegis to Hold

Aegis lowered shares of Cynosure, Inc. (NASDAQ:CYNO) from a buy rating to a hold rating in a research note released on Wednesday morning.

Several other brokerages also recently issued reports on CYNO. Northland Securities reissued an outperform rating and set a $60.00 price objective on shares of Cynosure in a research report on Thursday, February 16th. Northcoast Research raised shares of Cynosure from a sell rating to a neutral rating in a research report on Tuesday, February 14th. Maxim Group downgraded shares of Cynosure from a buy rating to a hold rating and set a $66.00 price objective on the stock. in a research report on Tuesday, February 14th. Zacks Investment Research downgraded shares of Cynosure from a hold rating to a sell rating in a research report on Monday, January 9th. Finally, TheStreet raised shares of Cynosure from a hold rating to a buy rating in a research report on Wednesday, January 4th. One analyst has rated the stock with a sell rating, three have assigned a hold rating and five have issued a buy rating to the company’s stock. The stock currently has an average rating of Hold and a consensus price target of $57.88.

Analyst Recommendations for Cynosure (NASDAQ:CYNO)

Cynosure (NASDAQ:CYNO) opened at 66.00 on Wednesday. The firm has a market cap of $1.61 billion, a P/E ratio of 110.00 and a beta of 1.65. The company’s 50 day moving average is $61.02 and its 200 day moving average is $50.59. Cynosure has a 52-week low of $38.93 and a 52-week high of $66.65.

Cynosure (NASDAQ:CYNO) last issued its quarterly earnings data on Tuesday, February 7th. The company reported $0.44 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.41 by $0.03. Cynosure had a net margin of 3.56% and a return on equity of 6.86%. The company had revenue of $122.10 million for the quarter, compared to the consensus estimate of $119.97 million. During the same period last year, the firm posted $0.42 EPS. Cynosure’s revenue for the quarter was up 19.2% on a year-over-year basis. Equities research analysts forecast that Cynosure will post $1.56 EPS for the current fiscal year.

Your IP Address:

Several hedge funds have recently modified their holdings of CYNO. Royal Bank of Canada increased its stake in shares of Cynosure by 52.6% in the second quarter. Royal Bank of Canada now owns 39,430 shares of the company’s stock valued at $1,918,000 after buying an additional 13,594 shares during the last quarter. Advisory Services Network LLC increased its stake in shares of Cynosure by 18.2% in the third quarter. Advisory Services Network LLC now owns 15,410 shares of the company’s stock valued at $785,000 after buying an additional 2,370 shares during the last quarter. Algert Global LLC increased its stake in shares of Cynosure by 37.6% in the third quarter. Algert Global LLC now owns 17,620 shares of the company’s stock valued at $898,000 after buying an additional 4,812 shares during the last quarter. Eagle Boston Investment Management Inc. increased its stake in shares of Cynosure by 0.7% in the third quarter. Eagle Boston Investment Management Inc. now owns 93,645 shares of the company’s stock valued at $4,770,000 after buying an additional 696 shares during the last quarter. Finally, 1st Global Advisors Inc. purchased a new stake in shares of Cynosure during the third quarter valued at $642,000.

About Cynosure

Cynosure, Inc develops, manufactures and markets aesthetic treatment systems that enable plastic surgeons, dermatologists and other medical practitioners to perform non-invasive and minimally invasive procedures to remove hair, treat vascular and benign pigmented lesions, remove multi-colored tattoos, revitalize the skin, reduce fat through laser lipolysis, reduce cellulite, clear nails infected by toe fungus, ablate sweat glands and improve women’s health.

5 Day Chart for NASDAQ:CYNO

This story was originally published by WKRB News (https://www.wkrb13.com) and is the sole property of WKRB News. If you are reading this article on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. You can view the original version of this story at https://www.wkrb13.com/markets/2024271/cynosure-inc-cyno-downgraded-by-aegis-to-hold.html

Receive News & Ratings for Cynosure Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cynosure Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

 


Leave a Reply

 
© 2006-2017 WKRB News.